Peru's Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details
Portfolio Pulse from Lara Goldstein
Magdalena Biosciences, Jaguar Health (NASDAQ:JAGX) and Filament Health (OTCQB:FLHLF) have formed a joint venture to develop plant-based medicines for mental health indications. They have imported Peruvian coca leaf to Canada for research into potential treatments for adult ADHD. The coca leaves were authorized for import by the Peruvian Health Authority and will be used in Filament’s facility, Psilo Scientific, for initial research purposes.
September 21, 2023 | 8:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Filament Health's partnership with Jaguar Health and Magdalena Biosciences to research potential ADHD treatments using Peruvian coca leaf could lead to the development of new, potentially safer treatments.
The partnership could lead to the development of new treatments for ADHD, a condition that affects a significant portion of adults. If successful, this could potentially boost Filament Health's market position and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jaguar Health's partnership with Filament Health and Magdalena Biosciences to research potential ADHD treatments using Peruvian coca leaf could lead to the development of new, potentially safer treatments.
The partnership could lead to the development of new treatments for ADHD, a condition that affects a significant portion of adults. If successful, this could potentially boost Jaguar Health's market position and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100